Pacific Biosciences Of California (PACB) Other Working Capital Changes (2010 - 2026)
Pacific Biosciences Of California (PACB) recorded quarterly Other Working Capital Changes of $2.3 million in Q1 2026, up 124.87% quarter-over-quarter from -$9.2 million in Q4 2025, and up 166.78% on a YoY basis from $857624.5 in Q1 2025.
Pacific Biosciences Of California (PACB) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Other Working Capital Changes history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 166.78% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at -$2.8 million (up 47.23% YoY), while the FY2025 annual figure was -$8.5 million, down 282.14% from the prior year.
- Other Working Capital Changes was $2.3 million for Q1 2026 at Pacific Biosciences Of California, up from -$9.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $15.9 million in Q4 2022 to a low of -$12.5 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$446588.2 across 5 years, with a median of -$845000.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes soared 2585.64% in 2022, then tumbled 447.95% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $15.9 million in 2022, then slumped by 114.86% to -$2.4 million in 2023, then tumbled by 31.32% to -$3.1 million in 2024, then tumbled by 196.46% to -$9.2 million in 2025, then soared by 124.87% to $2.3 million in 2026.
- The last three Other Working Capital Changes figures came in at $2.3 million (Q1 2026), -$9.2 million (Q4 2025), and -$123000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.29 Mn |
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | -9.20 Mn |
| Dec 31, 2025 | -9.20 Mn |
| Sep 30, 2025 | -123,000.00 |
| Sep 30, 2025 | -123,000.00 |
| Jun 30, 2025 | 4.23 Mn |
| Jun 30, 2025 | 4.23 Mn |
| Mar 31, 2025 | -3.43 Mn |
| Mar 31, 2025 | -3.43 Mn |
| Dec 31, 2024 | -3.10 Mn |
| Dec 31, 2024 | -3.10 Mn |
| Sep 30, 2024 | 5.62 Mn |
| Sep 30, 2024 | 5.62 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Mar 31, 2024 | -3.05 Mn |
| Mar 31, 2024 | -3.05 Mn |
| Dec 31, 2023 | -2.36 Mn |
| Dec 31, 2023 | -2.36 Mn |